Fluoroestradiol f 18
Cerianna (fluoroestradiol F-18) is an intravenous radioactive diagnostic agent manufactured by GE Healthcare. It emits positrons for PET imaging to help detect certain breast cancer lesions. Administered as a solution in a multi-dose vial, it's prescribed for medical use. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Cerianna (fluoroestradiol F-18) is an intravenous radioactive diagnostic agent manufactured by GE Healthcare. It emits positrons for PET imaging to help detect certain breast cancer lesions. Administered as a solution in a multi-dose vial, it's prescribed for medical use. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Fluoroestradiol f 18", "mediaType": "text/html", "description": " Access the FDA dataset for Fluoroestradiol f 18 — ANDA 212155 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212155" } ] |
| identifier | ANDA212155 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "drug-manufacturers", "fda", "pharmaceuticals", "prescription-drugs" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Fluoroestradiol f 18 |
